Effects of Angiotensin-1 Converting Enzyme inhibition on oxidative stress and bradykinin receptor expression during doxorubicin-induced cardiomyopathy in rats

Carole Richard (1, 2, 3) , Benjamin Lauzier (1) , Stéphanie Delemasure (1) , Sébastien Talbot , Stéliana Ghibu (1) , Bertrand Collin (1) , Jacques Sénécal , Franck Menetrier , Catherine Vergely (1, 2, 3) , Réjean Couture , Luc Rochette (1, 2, 3)

1 LPPCE - Laboratoire de Physiopathologie et de Pharmacologie Cardiovasculaire Expérimentale
2 LPPCM - Laboratoire de Physiopathologie et Pharmacologie Cardio-Métaboliques (U866, Lipides et nutrition, équipe 5)
3 PEC2 - Physiopathologie et épidémiologie cérébro-cardiovasculaire [Dijon]

Mots clés: Mechanism of anthracycline-induced cardiotoxicity Anthracycline; Angiotensin-1 Converting Enzyme Inhibitor; cardiotoxicity; oxidative stress; inflammation; kallikrein-kinin system

Domaines: Cardiologie et système cardiovasculaire

Carole Richard, Benjamin Lauzier, Stéphanie Delemasure, Sébastien Talbot, Stéliana Ghibu, et al.. Effects of Angiotensin-1 Converting Enzyme inhibition on oxidative stress and bradykinin receptor expression during doxorubicin-induced cardiomyopathy in rats. Journal of Cardiovascular Pharmacology, 2008, 52 (3), pp.278-285. ⟨10.1097/FJC.0b013e3181865f28⟩. ⟨hal-03437191⟩